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Thymus-derived (T) 1 lymphocytes mediate a  variety of immunological functions. 
The antigen specificity revealed in their responses postulates the existence of specific 
T  cell receptors (1-3). Antigen-specific receptors of B cells consist of immunoglobulin 
(Ig)  molecules and can be blocked by antibodies to constant region determinants of 
Ig  molecules  (4-6).  The  nature  of the  specific  T  cell  receptor,  however,  is  still 
controversial. Idiotype studies suggest the expression of Ig heavy chain variable gene 
products on T  cell receptors, although conventional Ig constant determinants have 
not been demonstrated (7-9).  Thus, if T  cell receptors, like those of B cells,  possess 
constant  regions  and  if T  cell  functions could  be  blocked  by  antibodies  to  such 
constant  determinants,  studies  on  the  nature  of T  cell  receptors  may be  greatly 
facilitated. 
Lymphocyte differentiation (Lyt)  antigens are  useful markers  for T  lymphocyte 
subpopulations. Although several systems of Lyt antigens are known, the Lyt-1 system 
and the Lyt-2,3 system have been most extensively characterized (10-12). T cells with 
different functions, particularly helper and killer activities, can be distinguished on 
the basis of their Lyt phenotype. Thus, with only few exceptions (13,  14), it has been 
widely accepted, that helper cells express the Lyt-l+2-3  -  phenotype, whereas killer 
cells have the Lyt-l-2+3  + phenotype (15). The question with regard to Lyt antigens 
is whether they play a role in the function of T  cells. 
Previous attempts to block T  cell killing of allogeneic target cells by a  variety of 
antibodies including Lyt antisera (in the absence of added complement) were generally 
unsuccessful (16,  17), although successful blocking studies with Lyt 2 antibodies have 
been recently reported  (18,  19). The availability of highly specific high titer mono- 
clonal  antibodies,  reactive  with  T  cell  membrane  components,  prompted  us  to 
investigate the effect of these antibodies on T  cell-mediated cytotoxicity and T  cell- 
proliferative  responses.  In  this  paper  we  describe  the  inhibition  of certain  T  cell 
functions by anti-Lyt-2 antibodies. 
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Materials and Methods 
Mice.  8- to  12-week-old BALB/c, CBA/J, AKR/J, DBA/2J, C3H/eJ, SWR/J, BALB/B, 
BALB/K,  and C57BL/6J male mice were used. 
Target  Cells.  LSTRA-Moloney virus-induced lymphoma cells  of BALB/c  origin, P815- 
mastocytoma cells of DBA/2 origin, EL-4 lymphoma cells of C57BL/6 origin, and MSV85- 
Moloney virus-induced sarcoma cells  of BALB/c  origin, were  used  as  target  cells  for  cell- 
mediated lymphocytotoxicity (CML) assays. They were maintained in culture as cell lines. 
Antibodies.  Monoclonal Lyt-1  (subclone 53 - 7.313) and Lyt-2 (subclone 53 - 6.72) antibody- 
producing hybridoma cell lines were a generous gift from J. Ledbetter of Stanford University. 
They secrete  ),2A antibodies directed to constant determinants of mouse Lyt-1  and Lyt-2 (20). 
31-11  is a  monoclonal rat y2A antibody directed to a constant determinant of mouse Thy-1 
(21). 42-21 is a monoclonal rat IgM antibody directed to a constant determinant of mouse Thy- 
1 (22). 43-13 is a monoclonal rat y2B antibody specific for an AKR thymic lymphoma antigen 
(2 I). All antibodies were harvested from cultures of the hybridoma cells. To be able to use high 
antibody concentrations in small volumes, hybridoma culture media supernates were precipi- 
tated with 50% ammonium sulfate, the precipitate was dissolved in a  10th of the initial volume, 
and dialyzed four times against RPMI-1640 medium. 
Pretreatment of Cells with  Anti-  (a)  Lyt  and  Complement (C).  Because the  monoclonal Lyt 
antibodies which we used for blocking studies were not cytotoxic with complement, (although 
they are efficient in sandwich cytotoxicity systems [J. Ledbetter. Personal communication.]), 
conventional Lyt  antisera were used  for  this purpose.  Pelleted spleen cells  (10  X  106) were 
suspended in 0.4 ml antiserum diluted 1:10 in medium and incubated for 30 min at 4°C. The 
cells were then washed once and resuspended in 1.5 ml of rabbit serum diluted 1:8 in medium. 
After incubation at 37°C for 30 rain the cells were washed twice and resuspended in the culture 
medium. 
Generation of Effector Cells.  For generation of allogeneic killer cells 2 ×  10  v spleen cells were 
cultured with 2 ×  10  7 mitomycin C-treated stimulator spleen cells (mitomycin C added at 40 
/~g/ml for  1 h) in 5 ml of RPMI 1640 medium supplemented with glutamine, antibiotics, 0.05 
mM 2-mercaptoethanol, and 15% heat-inactivated fetal calf serum (FCS). Cells were harvested 
after 4 d in culture and tested for cytolytic activity. Purified T cells were prepared by passage 
of spleen cells over nylon wool columns (23). Nylon wool nonadherent spleen cells are usually 
75-85% Thy-1 positive in our laboratory, as compared to 25-30% of untreated spleen cells. For 
generation of syngeneic killer cells, BALB/c mice were injected intramuscularly with Moloney 
sarcoma virus (M-MSV). Spleen cells were assayed for killing activity 14 d after immunization. 
Such spleen cells do not lyse Moloney-infected C57BL/6J cells, nor do C57BL/6J Moloney- 
immune spleen cells lyse LSTRA or MSV85 targets. 
Cell-mediated Cytotoxicity Assay.  Cytotoxic activity was assayed in microtiter plates containing 
1 ×  104 51Cr-labeled  target  cells  and 2  ×  105 allogeneic effector  cells  or  1 ×  106 syngeneic 
effector  cells in 0.2 ml medium per well. The plates were incubated for 3 h (allogeneic killing) 
or for 6 and 14 h (syngeneic killing) at 37°C. Cultures were terminated by centrifugation at 400 
g for  10 min at 4°C. Supernates were collected and counted in a  Beckman gamma counter 
(Beckman Instruments, Fullerton, Calif.) Percentage of specific lysis was calculated as follows: 
(experimental 51Cr release  -  spontaneous release)/(maximum 51Cr  release  --  spontaneous 
release)  ×  100. 
Mixed Lymphocyte Cultures (MLC).  Proliferative responses  of allogeneic mixed cells  were 
assayed  in microtiter plates.  2  ×  10  s  responder spleen cells  were  incubated with  2  ×  10  s 
mitomycin C-treated stimulator spleen cells in 0.2 ml medium per well. At 90 h, 1/zCi tritiated 
thymidine ([aH]TdR) was added, cultures were terminated at 96 h and [aH]TdR incorporation 
was determined. 
Activation  of Cells with  Concanavalin A  (Con A).  2  X  105  spleen cells  were  incubated in 
microplates in 0.2 ml medium containing 5/zg/ml Con A. At 48 h, 1 ttCi [3H]TdR was added, 
cultures were terminated at 54 h and [aH]TdR incorporation was determined. 
Analysis of Cell Populations by the Fluorescence-activated Cell Sorter (FACS).  2 X  106 cells were 
incubated with 0.1-ml monoclonal antibodies diluted 1:10 in medium +5% FCS. After a  20- 
rain incubation on ice, the cells were washed through FCS. The cell pellet was resuspended in 
0.05 ml ofa fluorescein-conjugated  rabbit.anti-rat Ig second stage and incubated for 20 min on 676  ROLE  OF  Lyt-2  ANTIBODIES  ON  T  CELL  FUNCTIONS 
ice. After an additional wash through FCS the cells were fixed in 1 ml of 1% formalin for FACS 
analysis. 
Results 
Blocking of Effector Cell Cytotoxicity by Lyt-2 Antibodies.  C57BL/6J effector cells were 
generated by in  vitro sensitization with  mitomycin C-treated  BALB/c spleen cells 
and tested for cytotoxicity against BALB/c LSTRA (H-2  d) and DBA/2 P815 (H-2  d) 
target cells. The effect of Lyt antibodies on killer cell activity in the absence of added 
complement is shown in Table I. P815 target cells, known as extremely fragile, and 
LSTRA  cells,  which  are  less  sensitive  targets,  were  used  in  parallel  to  exclude a 
possible influence of the overall efficiency of the killing system on the results obtained. 
With both target cells, blocking of cytotoxicity was mediated by aLyt-2 but  not by 
aLyt- 1. Blocking by aLyt-2 is at the level of the effector cells and not the target cells, 
because both  LSTRA and  P815  cells do not  bind  Lyt antibodies.  31-11  (aThy-1) 
antibodies, which bind to the effector cells to the same  (or greater) extent as Lyt-2 
antibodies  (Table VI),  did  not  block cytotoxicity, indicating  that  mere coating of 
killer  cells  with  antibodies  is  insufficient  to  inhibit  the  cytolytic  activity.  43-13 
antibodies are specific for an AKR  thymic lymphoma and  do not  bind  to normal 
lymphoid cells (21). Because they were produced and processed by the same procedure 
as the other antibodies, they were used as negative controls, to exclude a nonspecific 
effect of concentrated Ig on cytotoxic reactions. 
Lyt antibodies were further tested  for their effect on  killing of syngeneic tumor 
cells.  BALB/c mice were injected with MSV and the cytotoxic activity of their spleen 
cells was assessed using as target cells both LSTRA-BALB/c Moloney virus-induced 
iymphoma cell line, and MSV85-BALB/c Moloney virus-induced sarcoma cell line. 
The two different target cells were employed because it had been suggested that  T 
cells reactive in short-term killing of lymphoma cells are distinct with respect to their 
Lyt phenotype from those reactive against adherent cells (24).  As shown in Table II, 
aLyt-2 blocked killing of both LSTRA and MSV85 target cells, whereas no blocking 
effect could be demonstrated with aLyt-1 or c~Thy-1. 
Blocking of Mixed Lymphocyte Reactions by Lyt-2 Antibodies.  Proliferation of T  cells was 
TABLE  I 
Inhibitory Effect of aLyt-2 Antibodies on Allogeneic Killer Cells  * 
Experi-  Target cells 
ment 
Antibodiesz~ 
43-13  31-1l  aLyt-1  aLyt-2 
P815  66§  66  81  67  2711 
LSTRA  30  37  35  35  7¶ 
2  P815  50  ND**  42  46  15 u 
LSTRA  35  ND  24  36  5¶ 
* C57BL/6J  spleen cells were sensitized in vitro to BALB/e cells. For details on the 
cytotoxicity assay see Materials and Methods. 
:1: Antibodies added at a final dilution of 1:8. 
§ Percent specific 51Gr release in the presence of the indicated antibodies. 
][ Significantly lower than control (P ~  0.001). 
¶ Significantly lower than control (P <  0.01). 
** Not determined. NURIT HOLLANDER, ERIC  PILLEMER, AND IRVING  L.  WEISSMAN 
TABLE II 
Inhibitory Effect of otLyt-2 Antibodies on Syngeneic Killer Cells * 
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Experi-  Target cells 
ment 
Antibodies:~ 
43-13  31-11  otLyt- 1  otLyt-2 
LSTRA  23§  23  32  21  311 
MSV85  19  26  27  29  7¶ 
2  LSTRA  32  34  58  39  1311 
MSV85  33  35  25  47  11¶ 
* BALB/c mice were injected intramuscularly with Moloney sarcoma virus. Spleen 
cells were assayed for cytotoxic activity 14 d after immunization. 
:~ Antibodies  added at a final  dilution of 1:8. 
§ Percent specific 51Cr release in the presence of the indicated antibodies. 
II Significantly  lower than control (P < 0.001). 
¶ Significantly  lower than control (P < 0.02). 
TABLE  III 
Inhibitory Effect of aLyt-2 Antibodies on Cell Proliferation m MLC* 
Experi-  Antibodies:~  Percent 
inhibition  ment  --  43-13  31-11  ~tLyt- 1  aLyt-2§  by etLyt-2 
1  82,77711  81,435  83,150  91,156  32,278  60 
2  118,052  83,210  ND¶  94,994  36,050  71 
3  128,692  90,188  88,553  101,981  41,408  68 
4  54,067  65,363  ND  102,622  21,856  60 
* C57BL/6J responder spleen cells were cultured with mitomycin C-treated BALB/c 
cells. Thymidine incorporation was determined at 96 h. 
:]: Antibodies added at a final dilution of 1:20 at times 0, 24, 48, and 72 h. 
§ Values for aLyt-2 are statistically different from control values (P < 0.001). 
II Counts per minute in the presence of the indicated antibodies. 
¶ Not determined. 
induced by allogeneic stimulation in MLC.  0.01  ml of antibodies was  successively 
added to each culture at time 0, 24, 48, and 72 h. No complement was added.  [3H]- 
TdR  was  added  at  90  h  and cultures were  harvested  at  96  h.  The  results of four 
independent experiments are presented in Table III. The pattern of antibody effects 
on MLC resembled that observed for cytolysis, namely: aLyt-2 inhibited cell prolif- 
eration in response to aliogeneic stimulus, whereas ~xLyt-1 or c~Thy-1 exerted no effect 
on  the  response;  in  fact,  in  some  experiments  ~Lyt-I  enhanced  the  proliferative 
response. Cell proliferation was inhibited by anti-Lyt-1 antibodies as well when nylon 
wool-purified spleen lymphocytes were responding in MLC  (Table IV). Thus, anti- 
Lyt-2 antibodies exert  the same effect on whole spleen cell populations and on cell 
preparations enriched for T  cells. 
It  is widely accepted  that  both  Lyt-1 ÷  and Lyt-2  +  cells contribute to  the  MLC 
response to allogeneic antigens (15, 25). As shown in Table V, we ascertained that our 
cultures follow this rule. Thus, pretreatment of responder cells with either Lyt-1  or 
Lyt-2 antibodies and complement reduced subsequent proliferation in MLC; deple- 
tion  of Lyt  1  ÷  cells  resulted  in  74%  reduction, whereas  depletion of Lyt  2 +  cells 
resulted in 46% reduction in MLC  activity. The finding that  Lyt-2 antibodies, but 678  ROLE  OF Lyt-2 ANTIBODIES ON  T  CELL  FUNCTIONS 
TABL~ IV 
Inhibitory Effect of ctLyt-2 Antibodies on Proliferation of Nylon  Wool-purified Spleen 
Cells * 
Antibodies:]:  Percent 
Experiment  inhibition 
--  31-11  aLyt-1  aLyt-2 
1  25,582§  NDII  31,377  6,291  75 
2  22,109  25,057  31,60l  9,175  60 
* C57BL/6J responder spleen cells were passed over nylon wool columns and cultured 
with mitomycin C-treated BALB/c cells. Thymidine incorporation was determined 
at 96 h. 
:~ Antibodies added at a final dilution of 1:20. 
§ Counts per minute in the presence of the indicated antibodies. 
II Not determined. 
TABLE V 
The Effect of Pretreatment with Lyt Antiserum and C on the Capacity to 
Proliferate m MLC 
C57BL/6J  spleen cells treated  Percent 
Experiment  with:*  cpm  inhibition 
1  C  64,185 
2  otLyt-1 + C  16,680  74 
3  aLyt-2 + C  35,009  46 
4  Cells of groups 2 and 3 mixed  60,728  6 
(1:1 ratio) before culture 
* After treatment of C57BL/6J  spleen cells with  antibodies  and C, cells in 
each  group were adjusted  to the same  final concentration  of viable cells, 
mixed with BALB/c stimulator cells and cultured for 4 d. 
not Lyt-1 antibodies, blocked MLC  when present in the cultures (Table III) in spite 
of a  requirement  for  both  Lyt-1 +  and  Lyt-2  +  subclasses,  indicates  a  functional  or 
structural difference between Lyt-1 and Lyt-2. 
It  should  be  noted  that  the  inhibition  levels  (60-70%)  of cell  proliferation,  as 
assessed by thymidine incorporation, are in fact higher (75-88%)  when considering T 
cell proliferation, since 20% of the lymphoblasts in the MLC were non-T cells (Table 
VI), thus resistant to antibodies against T  cell antigens. Such high inhibition levels by 
aLyt-2 would be conceivable if the majority of T  cells proliferating on  the 5th  d  of 
MLC  are of Lyt-2 phenotype. The cells harvested after 4  d  in culture were therefore 
stained with  Lyt  antibodies  followed  by  a  fluorescein-conjugated  rabbit  anti-rat 
reagent, and  analyzed by the FACS. As shown  in Table VI, the harvested lympho- 
blasts expressed predominantly Lyt-2. Although 50% of MLC-induced blast cells were 
positive  for  Lyt-1,  the  intensity  of their  stain  was  very close to  background.  (The 
median  fluorescense was  only 9  units  above background,  compared  to  56  units  for 
Lyt-2.) This dull staining was not caused by technical problems, because unstimulated 
spleen cells and  Con  A-induced blast cells were brightly stained by the same Lyt-1 
antibodies,  It  therefore  appears  that  mixed  lymphocyte reactions  select  for  Lyt-2  + 
cells. Whether the Lyt-2  + MLC-induced blast cells also express low amounts of Lyt-1 
or are Lyt-1- cannot  be concluded  from  the FACS-analysis, because fluorescence is NURIT  HOLLANDER,  ERIC  PILLEMER,  AND  IRVING  L.  WEISSMAN 
TABLE  VI 
Typing of Cells Proliferating  in MLC and in Response to Con A 
Antibodies used for  Median  Percent 
Test cells  first stage pretreat-  positive  fluores- 
ment*  cence¢ 
Normal spleen cells  ctLyt-1  22.3  57 
aLyt-2  15.4  46 
31-11  28.8  91 
43-13  0.2  -- 
--  0.7  -- 
679 
MLC-induced blast cells  aLyt- 1  50.0  9 
aLyt-2  71.8  56 
31-11  80.6  60 
43-13  2.6  -- 
--  1.7  -- 
Con A-induced blast cells  aLyt- 1  66.6  45 
aLyt-2  81.2  53 
31 - 11  86.6  88 
43-13  1.2  -- 
--  1.2  -- 
* Treatment of cells with the indicated antibodies as first stage, was followed 
by  treatment with fluorescein-conjugated rabbit anti-rat Ig antibodies as 
second  stage.  Cells  were  then  analyzed  by  the  FACS  for  percentage  of 
positive cells and intensity of their stain. Only large blast cells were analyzed. 
:[: FACS units expressing intensity of cell staining as compared to background 
fluorescence. 
TABLE  VII 
The Effect of Lyt Antiserum  and C on the Capacity of MLC-Blasts to 
Proliferate * 
Percent 
Experiment  Treatment  cpm  inhibition~ 
1  C  44,596 
2  aLyt-I +  C  36,152  24 
3  aLyt-2 +  C  19,794  71 
4  aLyt-I +  12,722  91 
aLyt-2 +  C 
5  42-21 +  C  9,258 
* C57BL/6J anti-BALB/e lymphoblasts were harvested on 5th d of MLC and 
treated with Lyt antiserum and complement. Cells were labeled with [aH]- 
TdR after treatment and thymidine uptake was determined. 
:]: Because 42-21 antibodies kill  100% of T  cells, cpm after treatment with 42- 
21 were used as background for calculation of percent inhibition by aLyt. 
measured  by  arbitrary  units.  Borderline  levels  should  therefore  be  considered  on  a 
quantitative,  rather  than  exclusively qualitative, basis. 
To  study  further the Lyt  phenotype  expressed  by cells proliferating in MLC,  cells 
harvested  on  the  5th  d  of MLC  were  assayed  for  thymidine  uptake  after  treatment 
with  Lyt  antibodies  and  complement.  As  shown  in  Table  VII  treatment  of MLC- 
stimulated cells with aLyt-2 and complement  significantly reduced their proliferation. 
42-21  is a  monoclonal  IgM  antibody  directed to mouse Thy-1.  It is a  highly efficient 680  ROLE OF Lyt-2 ANTIBODIES ON T  CELL FUNCTIONS 
cytolytic antibody which  kills  100%  of T  cells,  including  MLC-induced  blast  ceils. 
When compared to thymidine uptake after  treatment  with 42-21  plus complement, 
aLyt-2 plus complement eliminated 71% ofMLC-induced T cell proliferation, whereas 
aLyt-I  plus  complement  eliminated  only  24%  of the  proliferating  activity.  These 
results indicate, in agreement with the data obtained by staining, that the majority of 
T  cells proliferating on the 5th d  of MLC are of Lyt-2 phenotype. 
The Effect of T  Cell Monoclonal  Antibodies on the  T  Cell Response  to Con A.  The effect 
of Lyt-1, Lyt-2, and Thy-1 antibodies on the polyclonal activation of T  cells by Con 
A  was studied.  0.01  ml of antibodies  was added to each culture  at  time 0  and  24 h, 
[3H]TdR  was  added  at  48  h  and  cultures  were  harvested  at  54  h.  The  results, 
summarized  in  Table  VIII,  demonstrate  that  distinct  effects  are  mediated  by  the 
antibodies  on Con A  activation,  as compared to allogeneic activation.  Thus, Con A 
cultures were inhibited  by aThy-1, but not by aLyt-2, whereas MLC was blocked by 
aLyt-2,  but  not  by  aThy-1,  aLyt-1  did  not  affect  either  Con  A  or  allogeneic 
stimulation;  in fact it occasionally enhanced the proliferative responses. 
Although aThy-1 reproducibly inhibited  Con A-mediated cell proliferation,  levels 
of inhibition were variable, ranging from 40 to 80%, and dependent on high antibody 
concentrations.  As shown  in  Table  IX, aThy-1  had  no effect  when  added  at  final 
dilution of 1:100. This is in contrast to the inhibition  of MLC by aLyt-2, which was 
as effective at  1:100 as at  1:20 dilution, and in fact could be diluted to concentrations 
lower than  1  : 100 without losing activity (not shown). It therefore seems that inhibition 
of MLC by aLyt-2 and  inhibition  of Con A  activation  by aThy-1  are  mediated  by 
different blocking mechanisms. 
The  Effect  of Lyt-2  Antibodies  on  T  Cells  of Different  Mouse  Strains.  To  ascertain 
whether  the  inhibition  of Lyt-2  + T  cell  function  by aLyt-2  antibodies  is  a  general 
phenomenon,  the  experiments  described  for C57BL/6  anti  BALB/c reactions  were 
repeated with other mouse strain combinations.  As shown in Table X, cell-mediated 
cytotoxicity was generally blocked by aLyt-2 in all strain combinations.  Blocking by 
aLyt-2 is at the level of the effector cells, since both P815 and EL4 target cells do not 
bind Lyt-2 antibodies. 
However, when cell proliferation in MLC was tested,  quantitative differences were 
observed between  different strain combinations;  spleen cells of certain  mouse strains 
were more readily blocked by aLyt-2 than others  (Table XI). In general, C57BL/6J 
TABLE VIII 
Con A-induced Lymphocyte Proliferation in the Presence of a Thy-1 and aLyt Antibodies * 
Antibodies:~  Percent inhibi- 
Experiment  tion by otThy-  1 
--  43-13  31-11§  ~Lyt- 1  aLyt-2 
1  189,502[[  179,840  99,496  440,257  177,470  47 
2  120,001  78,965  19,212  267,465  88,249  84 
3  146,426  107,287  76,991  156,508  130,086  48 
4  111,897  74,910  43,735  131,835  102,719  62 
5  107,891  79,042  ND¶  116,773  97,228  ND 
* C57BL/6J spleen cells activated by 5/~ Con A/ml. Thymidine incorporation was determined at 54 h. 
:~ Antibodies at a final dilution of 1:20 were added at times 0 and 24 h. 
§ Values for 31-11 (aThy-1) are statistically different from control values (P < 0.001). 
[[ CPM in the presence of the indicated antibodies. 
¶ Not determined. NURIT HOLLANDER, ERIC  PILLEMER, AND IRVING  L.  WEISSMAN 
TABLE IX 
Comparison of aLyt-2 and a Thy-I Inhibitory  Effect on Lymphocyte 
Proliferation 
Antibodies added 
Proliferation induced by: 
Con A  MLC 
43-13 
31-11 
aLyt- 1 
aLyt-2 
154,152*  84,882 
1:20  153,790  78,217 
I: 100  287,457  92,437 
1:20  94,114  68,139 
1 : 100  221,888  102,925 
1:20  321,325  82,057 
1:100  463,307  106,845 
1:20  314,101  35,344 
1  : 100  230,826  32,585 
* Counts per minute in the presence of the indicated antibodies. 
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TABLE  X 
Inhibitory  Effect of etLyt-2 Antibodies  on A llogeneic Killer Cells of Different 
Strains * 
Killer cells  Target cells 
Antibodies~ 
--  aLyt- 1  aLyt-2 
C57BL/6J anti-BALB/c  P815  83§  77  38 
DBA/2J anti-C57BL/6J  EL  31  28  7 
CBA/J anti-C57BL/6J  EL  42  39  9 
CBA/J anti-BALB/c  P815  77  87  30 
AKR/J anti-C57BL/6J  EL  58  51  9 
AKR/J anti-BALB/c  P815  83  84  34 
* Killer cells were induced for 4 d in MLC. 
Antibodies added at a final dilution of 1:8. 
§ Percent specific SlCr release in the presence of the indicated antibodies. 
cells manifested the highest inhibition rate, BALB/c and CBA cells were significantly 
blocked, but with an inhibition percentage somewhat  lower than the rates  demon- 
strated by C57BL/6 cells, and AKR or DBA/2 cells manifested low inhibition rates. 
A possible explanation to account for such differences between various strains may be 
a  quantitative difference in the fraction of Lyt-2  + cells proliferating in MLC. Nylon 
wool- purified normal 'spleen cells of the various strains were therefore stained with 
Lyt antibodies followed by fluorescein-conjugated  rabbit anti-rat reagent and the Lyt 
phenotype  of  the  cells  was  analyzed.  Striking  differences  were  found  in  the  Lyt 
phenotype of different  mouse strains  (Table XII).  C57BL/6  normal spleen T  cells 
contain a very large fraction of Lyt-2 cells, compared to other strains. MLC blast cells 
also exhibited differences in the cell fraction positive for Lyt-2 (Table XIII), although 
not as marked as the differences demonstrated for normal cells, possibly because MLC 
reactions  select  for  Lyt-2  ÷  cells  which  proliferate  and  take  over  the  culture.  As 682  ROLE  OF Lyt-2 ANTIBODIES  ON  T  CELL  FUNCTIONS 
TABLE XI 
Inhibitory Effect of aLyt-2 Antibodies on MLC Carried Out with Different 
Strain Combinations 
Percent inhibition  Experiment  Strain combination  by aLyt-2 
l  C57BL/6J  anti-BALB/c  51 
BALB/c anti-C57BL/6J  41 
CBA/J anti-BALB/c  46 
CBA/J anti-C57BL/6J  9 
AKR/J anti-SWR/J  31 
AKR/J anti-C57BL/6J  24 
C57BL/6J  anti-BALB/c  51 
C57BL/6J  anti-C3H/eJ  59 
BALB/c anti-CaH/eJ  33 
DBA/2J anti-SWR/J  36 
CBA/J anti-SWR/J  21 
CBA/J anti-BALB/c  33 
C57BL/J anti-BALB/c  55 
C57BL/J  anti-CBA/J  58 
C57BL/J  anti-AKR/J  38 
C57BL/J anti-DBA/2J  60 
BALB/c anti-C57BL/6J  40 
BALB/c anti-CBA/J  47 
BALB/c anti-AKR/J  56 
CBA/J anti-BALB/c  54 
AKR/J anti-BALB/c  27 
TABLE XII 
Lyt Phenotype of Normal Spleen Cells Derived from Different Strains * 
Strain 
Percent of T cells:[: 
Lyt- 1  Lyt-2 
C57BL/6J  90  72 
BALB/c  86  25 
CBA/J  85  38 
DBA/2J  92  28 
AKR/J  92  42 
* Nylon wool-purified spleen cells were typed. 
Cells were stained with 31-11 (aThy-l), aLyt-l, and otLyt-2.  The fraction of 
Lyt-l- and Lyt-2-positive cells was calculated  as percentage of the Thy-1- 
positive cells. 
mentioned above, since MLC-induced lymphoblasts express very low amounts of Lyt- 
1 with  staining  intensity close to  background,  no  qualitative  differences regarding 
Lyt- 1 phenotype can be detected. However, since Lyt-2 staining ofMLC  lymphoblasts 
is very bright, it may be concluded, that MLC-induced blast cells differ in the fraction 
of Lyt-2  + cells when different strains are tested. This finding accounts for the observed 
differences in efficiency of MLC-inhibition by aLyt-2. It should be noted, however, 
that of 16 strain combinations tested, none was blocked by aLyt-1  (data not shown); 
MLC blocking was mediated by aLyt-2 exclusively. Anti-Lyt-2 antibodies also blocked NURIT  HOLLANDER,  ERIC  PILLEMER,  AND  IRVING  L.  WEISSMAN  683 
TABLE  XIII 
Typing of Cells Proliferating in MLC of Different Strain Combinations 
Strain combination 
Percent of T cells* 
Lyt- 1  Lyt-2 
C57BL/6J anti-BALB/c  50  77 
C57BL/6J anti-AKR/J  81  90 
BALB/c anti-C57BL/6J  40  53 
BALB/c anti-AKR/J  80  49 
BALB/c anti-CBA/J  72  60 
DBA/2J anti-C57BL/6J  50  23 
DBA/2J anti-AKR/J  70  41 
DBA/2J anti-CBA/J  70  41 
CBA/J anti-C57BL/6J  54  62 
DBA/J anti-BALB/c  75  45 
AKR/J anti-C57BL/6J  84  31 
AKR/J anti-BALB/c  75  54 
* Cells were stained with 31-11 (aThy-l), aLyt-l, and aLyt-2. The fraction of 
Lyt-l- and Lyt-2-positive cells was calculated as percentage of the Thy-1- 
positive cells. Only large lymphoblasts were analyzed. 
TABLE  XIV 
Inhibitory Effect of aLyt-2 Antibodies on MLC of Congenic Strab~s* 
Percent inhibition by  Strain combination  aLyt-2 
BALB/c anti-BALB/B  48 
BALB/c anti-BALB/K  46 
BALB/B anti-BALB/c  62 
BALB/K anti-BALB/c  45 
* Mice with BALB background were used.  BALB/c  :H-2  a,  BALB/B: H-2 b, 
BALB/K: H-2 k. 
MLC when congenic BALB combinations were studied (Table XIV), indicating that 
Lyt-2 antibodies are effective both in MLC induced by H-2 differences alone or by 
H-2 in combination with other possible allogeneic differences. 
Discussion 
Previous attempts to block allogeneic killer cells by alloantibodies and xenoanti- 
bodies  to  various  T  cell surface  antigens  have  generally  failed  (16,  17),  although 
blocking of allogeneic cytotoxicity by Lyt-2 antibodies has been recently reported (18, 
19). In the present study we succeeded in blocking effector function of killer cells by 
Lyt-2 antibodies in the absence of complement. Both short term killing of allogeneic 
cells and  longer syngeneic cytotoxic responses against  lymphoma or sarcoma target 
cells were inhibited. The blocking is at the level of the effector cells which bind the 
antibodies, rather than the target cells, which do not react with the antibodies. The 
discrepancy between the present observation and previous reports that Lyt-2 antibod- 
ies do not inhibit CML (16,  17)  may be explained by differences in the antibodies. 
We used rat monoclonal antibodies, which recognize a constant region determinant 
of mouse Lyt molecule, whereas other investigators used conventional alloantisera, 
directed  to  the  Ly alloantigens  1 and  2.  Xenoantibodies  against  constant  region 684  ROLE OF Lyt-2 ANTIBODIES ON T  CELL FUNCTIONS 
determinants may be more potent in inhibition of CML than the alloantibodies used 
in  the  past.  Nevertheless,  it  has  been  recently  reported  that  after  screening  of 
individual sera, few anti-Lyt-1 alloantisera were found to inhibit CML (18,  19). Our 
observations  reinforce  these  findings  and  corroborative  data  (W.  Seaman  et  al. 
unpublished  observations.)  demonstrating allogeneic cytotoxicity blockade on  P815 
cells with rat anti-Lyt-2 (53-6.72)  and anti Lyt 3 (53-5.8), indicating the significance 
of CML inhibition by Lyt-2 antibodies. 
The  significance  of Lyt-2  in  certain  T  cell  responses  is  further  stressed  by  the 
blocking effect of Lyt-2 antibodies on MLC. The finding that Lyt-1 antibodies do not 
interfere with MLC is of particular interest. Lyt-1  ÷ cells are required as helper cells 
for the proliferation of Lyt-2  ÷ cells and for the generation of Lyt-2  + killer cells. Thus, 
pretreatment of responder spleen lymphocytes with aLyt-1 and complement results in 
poor response to allogeneic stimuli. Whatever the helper mechanism of Lyt-1  ÷ cells, 
antibodies to Lyt- 1 have no effect on the helper function. If cells of Lyt- I phenotype 
proliferate in MLC, they do so only during early stages of the MLC. We demonstrated 
that although unstimulated spleen cells are strongly positive for both Lyt-1 and Lyt- 
2, after 4 d in culture the large cells are predominantly Lyt-2 positive, but negative or 
weakly  positive for Lyt-1. Thus,  in  the allogeneic MLC  which  we studied  there is 
selection  for proliferation  of Lyt-2  ÷  cells.  This  proliferation  is  inhibited  by  Lyt-2 
antibodies.  Whether  these  proliferating  Lyt-2  ÷  cells  are  Lyt-1  negative  or  weakly 
positive,  remains  undetermined.  It  has  been  recently suggested  that  differences in 
expression of Lyt- 1 antigen are quantitative rather than qualitative and therefore the 
designation high vs. low expression of Lyt-1 should be used instead of Lyt-1  + vs. Lyt- 
1-, even with regard to cytotoxic ceils (19). 
The observation of marked differences in  proportions of Lyt-2  ÷ ceils in  different 
strains was surprising. However, recent studies with monoclonal anti-Lyt-2 antibodies 
(26), similarly demonstrated a high proportion ofLyt-2  + cells in C57BL/6 as compared 
to BALB/c mice. This finding should call attention to studies on relative proportions 
and interactions of T  cell subsets, when different mouse strains are studied. 
The significance of Lyt-2 in  certain  T  cell responses  is  not  contradicted  by the 
differences in Lyt-2  ÷ cell proportion manifested by different strains. Functions of Lyt- 
2  ÷ cells, such as cell-mediated cytotoxicity and cell proliferation are blocked by anti- 
Lyt-2  antibodies  in  all  strains.  The  differences  in  Lyt-2  ÷  cell  proportions  is  only 
quantitatively reflected in our experiments by the efficiency of blocking MLC with 
aLyt-2. Obviously, in cultures which contain 50% Lyt-2  ÷ cells, only 50% of the activity 
would be blocked by aLyt-2. It should be noted, however, that even in cultures with 
relatively low proportions of Lyt-2  ÷ cells, aLyt-1 antibodies had no inhibitory effect, 
further emphasizing the significance of Lyt-2 molecules in T  cell functions. 
Although the aThy-1 and aLyt-1 antibodies used in our studies were of the same 
rat  T2A  immunoglobulin  class  as  the  Lyt-2 antibodies,  had  high  titers,  and  their 
binding to T  cells was as strong or stronger than that of Lyt-2 antibodies, they had 
little or no effect on CML or on MLC proliferation. The strong blocking activity of 
Lyt-2 antibodies therefore suggests a functional significance of Lyt-2 molecules. 
The mechanism of inhibition of CML and MLC is yet unclear, The possibility that 
agglutination could prevent T  cells from reacting with their stimulator or target cells 
seems unlikely, because other antibodies, such as aThy-1, showed comparable if not 
stronger binding  and  agglutinating  capacity, but  had  no inhibitory effect. For the NURIT  HOLLANDER,  ERIC  PILLEMER,  AND  IRVING  L.  WEISSMAN  685 
same  reason it is  unlikely  (although possible)  that  binding of antibodies alters cell 
surface in a way which prevents normal function. Such an explanation would imply 
a  peculiar nature of Lyt-2 molecules, which  following binding of antibodies cause 
membrane alteration not mediated by the reaction of antibodies with Lyt- 1 or Thy- 
1 cell membrane components. 
Another  possibility  is  that  Lyt-2  molecules,  though  distinct  from  the  antigen- 
receptor,  are  directly  involved  in  the  killing  of target  cells,  either  by  release  of 
mediators or by local interaction with the target cells. This explanation may provide 
a  correlation between the Lyt-2  + phenotype and function of killer cells.  However, it 
does not account for the observation that Lyt-2 antibodies inhibit cell proliferation in 
MLC. 
Lyt-2 antibodies may interfere with T  cell function at the leve 1 of T  cell receptors. 
If Lyt-2 determinants  are  adjacent  to  T  cell  receptors,  antibodies  bound  to  Lyt 
molecules may block the receptors by steric hindrance. An alternative possibility is 
that Lyt-2 is an integral part of the antigen-receptors. In this case, Lyt-2 determinants 
would likely be components of a  constant portion of the receptor. The finding that 
genes  for K-light  chain  are closely linked  to the  Lyt-2 genes  (27-29)  may imply a 
model whereby the receptor of the killer T  cell is composed of Lyt-2 determinants as 
a constant portion and Vk determinants as a variable part. Since helper cells are Lyt- 
1+2 -, and since a role oflg heavy chain-linked gene products in the antigen-combining 
sites of these helper cells has been suggested (7-9), one would have to speculate that 
different subsets of T  cells use different gene products for their receptors. 
Con A, a  polyclonal activator, stimulates T  cells to undergo proliferation events 
similar  to those induced by specific antigen.  However, in contrast to inhibition  of 
MLC by Lyt-2 antibodies, the same antibodies had no blocking effect on activation 
induced by Con A. This lack of inhibitory effect cannot be attributed to resistance of 
Lyt-2  + cells to Con A, because it has been reported that Con A activates Lyt-1 and 
Lyt-2 subclasses to the same degree (30), and we have demonstrated that lymphoblasts 
activated by Con  A  express both  Lyt-1  and  Lyt-2 antigens.  Con  A  stimulation  is, 
however, blocked by Thy-1 antibodies, when high antibody concentrations are added. 
It  may be that  Thy-1, as a  prominent  T  cell membrane component, is directly or 
indirectly associated with T  cell mitogenesis; hence, when all Thy-1 determinants are 
coated by anti-Thy-1 , mitogen-induced proliferation is blocked. Elsewhere we have 
demonstrated  that  monoclonal  anti-Thy-1  antibodies  are  extremely potent  in  the 
inhibition of proliferation of several neoplastic T  cell lymphomas, a phenomenon we 
ascribe to inhibition of triggering ofT-lymphoma mitogen receptors (21). It is possible 
that these T  lymphomas are neoplastic counterparts of some Con-A responsive T  cell 
subsets. Whatever the mechanism of Con A blocking by ~Thy-1 is, the fact that an 
antigen  driven  stimulation  is  sensitive  to  Lyt-2  antibodies,  whereas  nonspecific 
stimulation is resistant to the same antibodies, is in favor of the hypothesis that Lyt- 
2 antibodies interfere with T  cell functions at the level of T  cell antigen-receptor. 
Summary 
Monoclonal anti-Lyt-2 antibodies blocked effector function of cytotoxic thymus- 
derived (T) cells in the absence of added complement. Cytolysis of both allogeneic 
cells and syngeneic lymphoma or sarcoma target cells was inhibited at the level of the 
effector lymphocytes. Anti-Lyt-1 and anti-Thy-1 antibodies did not block killer cells. 686  ROLE OF Lyt-2 ANTIBODIES  ON T  CELL FUNCTIONS 
Proliferation of T  cells in mixed lymphocyte culture was also inhibited by anti-Lyt-2, 
but not affected by anti-Lyt- 1 or anti-Thy- 1 antibodies. Although Lyt- 1  + lymphocytes 
were  required  in  the  mixed  lymphocyte reaction  as  helper  cells  for proliferation  of 
Lyt-2  + lymphocytes, their helper function was not affected by the presence of Lyt-1 
antibodies.  Thus, although anti-  Lyt-1, anti-Lyt-2 and anti-Thy-1  were of the same 
y2A immunoglobulin  class, had high titers,  and interacted  with T  cells to the same 
extent, only anti-Lyt-2 blocked T  cell functions.  Polyclonal activation of T  lympho- 
cytes by concanavalin A, in contrast to activation by alloantigens, was not inhibited 
by Lyt-2 antibodies, suggesting that Lyt-2 antibodies interfere with T  cell function at 
the level of the T  cell antigen-receptor.  The role which Lyt-2 molecules may play in 
T  cell function is discussed. 
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